Cargando…

Causes of death and estimated life expectancy among people with diabetes: A retrospective cohort study in a diabetes clinic

We sought to estimate the exact causes of death, mortality rate and life expectancy of diabetes patients by analyzing death records in a diabetes specialist clinic in Japan. Of the 6,140 participants included in our analysis, the average age was 58.1 years and 77% were men. A total of 261 deaths wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goto, Atsushi, Takao, Toshiko, Yoshida, Yoko, Kawazu, Shoji, Iwamoto, Yasuhiko, Terauchi, Yasuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944819/ https://www.ncbi.nlm.nih.gov/pubmed/31111637 http://dx.doi.org/10.1111/jdi.13077

Ejemplares similares

C-Peptide Level in Fasting Plasma and Pooled Urine Predicts HbA1c after Hospitalization in Patients with Type 2 Diabetes Mellitus
por: Sonoda, Remi, et al.
Publicado: (2016)

Synergistic association of the copper/zinc ratio under inflammatory conditions with diabetic kidney disease in patients with type 2 diabetes: The Asahi Diabetes Complications Study
por: Takao, Toshiko, et al.
Publicado: (2021)

Impact of postprandial hyperglycemia at clinic visits on the incidence of cardiovascular events and all‐cause mortality in patients with type 2 diabetes
por: Takao, Toshiko, et al.
Publicado: (2017)

Twenty‐year trend of increasing obesity in young patients with poorly controlled type 2 diabetes at first diagnosis in urban Japan
por: Kushiyama, Akifumi, et al.
Publicado: (2013)

Decline in perception of acid regurgitation symptoms from gastroesophageal reflux disease in diabetes mellitus patients
por: Sakitani, Kosuke, et al.
Publicado: (2018)

The combined effect of visit-to-visit variability in HbA1c and systolic blood pressure on the incidence of cardiovascular events in patients with type 2 diabetes
por: Takao, Toshiko, et al.
Publicado: (2015)

Association Between Severe Hypoglycemia and Cardiovascular Disease Risk in Japanese Patients With Type 2 Diabetes
por: Goto, Atsushi, et al.
Publicado: (2016)

Association of self‐stigma with glycated hemoglobin: A single‐center, cross‐sectional study of adults with type 1 diabetes in Japan
por: Hamano, Shoko, et al.
Publicado: (2023)

Diabetes management by either telemedicine or clinic visit improved glycemic control during the coronavirus disease 2019 pandemic state of emergency in Japan
por: Onishi, Yukiko, et al.
Publicado: (2021)

Changes in Antidiabetic Drug Prescription and Glycemic Control Trends in Elderly Patients with Type 2 Diabetes Mellitus from 2005-2013: An Analysis of the National Center Diabetes Database (NCDD-03)
por: Yamamoto-Honda, Ritsuko, et al.
Publicado: (2017)

Effect of postprandial hyperglycemia at clinic visits on the incidence of retinopathy in patients with type 2 diabetes: An analysis using real‐world long‐term follow‐up data
por: Takao, Toshiko, et al.
Publicado: (2020)

Body mass index and the risk of cancer incidence in patients with type 2 diabetes in Japan: Results from the National Center Diabetes Database
por: Yamamoto‐Honda, Ritsuko, et al.
Publicado: (2016)

Associations of sex hormone-binding globulin and testosterone with diabetes among men and women (the Saku Diabetes study): a case control study
por: Goto, Atsushi, et al.
Publicado: (2012)

Clinical features and sulfonylurea usage among outpatients with diabetes aged ≥90 years in an urban diabetes clinic in Tokyo
por: Kobori, Toshiko, et al.
Publicado: (2022)

Causes of death in Japanese diabetics: A questionnaire survey of 18,385 diabetics over a 10‐year period
por: Hotta, Nigishi, et al.
Publicado: (2010)

Use of iGlarLixi for Management of Type 2 Diabetes in Japanese Clinical Practice: SPARTA Japan, a Retrospective Observational Study
por: Matsuhisa, Munehide, et al.
Publicado: (2022)

The Durable Safety and Effectiveness of Lixisenatide in Japanese People with Type 2 Diabetes: The Post-Marketing Surveillance PRANDIAL Study
por: Terauchi, Yasuo, et al.
Publicado: (2022)

Role of elevated serum uric acid levels at the onset of overt nephropathy in the risk for renal function decline in patients with type 2 diabetes
por: Tanaka, Kentaro, et al.
Publicado: (2015)

Gastric cancer diagnosed after Helicobacter pylori eradication in diabetes mellitus patients
por: Sakitani, Kosuke, et al.
Publicado: (2015)

Simultaneous Versus Sequential Initiation of Lixisenatide and Basal Insulin for Type 2 Diabetes: Subgroup Analysis of a Japanese Post-Marketing Surveillance Study of Lixisenatide (PRANDIAL)
por: Kaneto, Hideaki, et al.
Publicado: (2022)

The long-term coronary heart disease risk of previously obese patients with type 2 diabetes mellitus
por: Yamamoto-Honda, Ritsuko, et al.
Publicado: (2013)

Combined effect of diabetic retinopathy and diabetic kidney disease on all‐cause, cancer, vascular and non‐cancer non‐vascular mortality in patients with type 2 diabetes: A real‐world longitudinal study
por: Takao, Toshiko, et al.
Publicado: (2020)

Association of insulin treatment with gastric residue during an esophagogastroduodenoscopy
por: Kobori, Toshiko, et al.
Publicado: (2021)

Association of cardiovascular health with diabetic complications, all-cause mortality, and life expectancy among people with type 2 diabetes
por: Zhang, Yuan, et al.
Publicado: (2022)

Development and Validation of the Life Expectancy Estimator for Older Adults with Diabetes (LEAD): the Diabetes and Aging Study
por: Karter, Andrew J., et al.
Publicado: (2023)

Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study
por: Kaku, Kohei, et al.
Publicado: (2014)

Decreased response inhibition in middle-aged male patients with type 2 diabetes
por: Ishizawa, Kaya T, et al.
Publicado: (2010)

Use of iGlarLixi for the Management of Type 2 Diabetes in Japanese Clinical Practice: Prior Treatment Subgroup Analysis of the SPARTA Japan Study
por: Miyoshi, Hideaki, et al.
Publicado: (2023)

Selective and sequential loss of transcriptional factors: A hallmark of β‐cell failure in type 2 diabetes?
por: Shirakawa, Jun, et al.
Publicado: (2014)

Efficacy and Safety of GPR119 Agonist DS-8500a in Japanese Patients with Type 2 Diabetes: a Randomized, Double-Blind, Placebo-Controlled, 12-Week Study
por: Yamada, Yuichiro, et al.
Publicado: (2018)

Effect of Sitagliptin on Lipid Profile in Patients With Type 2 Diabetes Mellitus
por: Shigematsu, Erina, et al.
Publicado: (2014)

Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in Japanese people with type 2 diabetes
por: Seino, Yutaka, et al.
Publicado: (2017)

Efficacy and safety of the G protein‐coupled receptor 119 agonist DS‐8500a in Japanese type 2 diabetes mellitus patients with inadequate glycemic control on sitagliptin: A phase 2 randomized placebo‐controlled study
por: Terauchi, Yasuo, et al.
Publicado: (2018)

Life Expectancy Predictions for Older Diabetic Patients as Estimated by Physicians and a Prognostic Model
por: O’Hanlon, Claire E., et al.
Publicado: (2017)

Estimates of age specific death rates in people with diabetes and associated multimorbidity using Australian administrative pharmaceutical data
por: Purkiss, Shaun Francis, et al.
Publicado: (2021)

Effects of Canagliflozin on Hepatic Steatosis, Visceral Fat and Skeletal Muscle among Patients with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease
por: Nishimiya, Noriko, et al.
Publicado: (2021)

Validity and reliability of the Japanese version of the diabetes knowledge test among in‐patients with type 2 diabetes
por: Minami, Taichi, et al.
Publicado: (2021)

Sleep duration and food intake in people with type 2 diabetes mellitus and factors affecting confectionery intake
por: Akiyama, Tomoaki, et al.
Publicado: (2023)

Comparison of Lipid-Lowering Effects of Anagliptin and Miglitol in Patients With Type 2 Diabetes: A Randomized Trial
por: Iijima, Takahiro, et al.
Publicado: (2020)

Effects of switching from liraglutide to semaglutide or dulaglutide in patients with type 2 diabetes: A randomized controlled trial
por: Iijima, Takahiro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h47fql3bav8acl1h40f6abur4s